ID   PTN6_RAT                Reviewed;         613 AA.
AC   P81718;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   02-OCT-2024, entry version 155.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 6;
DE            EC=3.1.3.48;
DE   AltName: Full=Protein-tyrosine phosphatase SHP-1;
GN   Name=Ptpn6; Synonyms=Ptph6;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Aoki N., Yamaguchi-Aoki Y., Ullrich A.;
RT   "The rat SH2-containing protein-tyrosine phosphatase SHP-1 is a positive
RT   regulator of NGF-induced neuronal differentiation of PC12 cells.";
RL   Submitted (NOV-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, DEVELOPMENTAL STAGE, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   MTUS1.
RX   PubMed=17068200; DOI=10.1210/me.2006-0005;
RA   Li J.-M., Mogi M., Tsukuda K., Tomochika H., Iwanami J., Min L.-J.,
RA   Nahmias C., Iwai M., Horiuchi M.;
RT   "Angiotensin II-induced neural differentiation via angiotensin II type 2
RT   (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-
RT   interacting protein and Src homology 2 domain-containing protein-tyrosine
RT   phosphatase 1.";
RL   Mol. Endocrinol. 21:499-511(2007).
RN   [3]
RP   INTERACTION WITH KLRI1 AND KLRI2.
RX   PubMed=18713988; DOI=10.4049/jimmunol.181.5.3177;
RA   Saether P.C., Westgaard I.H., Hoelsbrekken S.E., Benjamin J., Lanier L.L.,
RA   Fossum S., Dissen E.;
RT   "KLRE/I1 and KLRE/I2: a novel pair of heterodimeric receptors that
RT   inversely regulate NK cell cytotoxicity.";
RL   J. Immunol. 181:3177-3182(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Tyrosine phosphatase enzyme that plays important roles in
CC       controlling immune signaling pathways and fundamental physiological
CC       processes such as hematopoiesis. Dephosphorylates and negatively
CC       regulate several receptor tyrosine kinases (RTKs) such as EGFR, PDGFR
CC       and FGFR, thereby modulating their signaling activities. When recruited
CC       to immunoreceptor tyrosine-based inhibitory motif (ITIM)-containing
CC       receptors such as immunoglobulin-like transcript 2/LILRB1, programmed
CC       cell death protein 1/PDCD1, CD3D, CD22 and other receptors involved in
CC       immune regulation, initiates their dephosphorylation and subsequently
CC       inhibits downstream signaling events. Modulates the signaling of
CC       several cytokine receptors including IL-4 receptor. Additionally,
CC       targets multiple cytoplasmic signaling molecules including STING1, LCK
CC       or STAT1 among others involved in diverse cellular processes including
CC       modulation of T-cell activation or cGAS-STING signaling. Within the
CC       nucleus, negatively regulates the activity of some transcription
CC       factors such as NFAT5 via direct dephosphorylation. Acts also as a key
CC       transcriptional regulator of hepatic gluconeogenesis by controlling
CC       recruitment of RNA polymerase II to the PCK1 promoter together with
CC       STAT5A. {ECO:0000250|UniProtKB:P29350, ECO:0000269|PubMed:17068200}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000250|UniProtKB:P29351, ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Monomer. Interacts with MTUS1 (PubMed:17068200). Interacts
CC       with MILR1 (tyrosine-phosphorylated) (By similarity). Interacts with
CC       KIT (By similarity). Interacts with SIRPA/PTPNS1. Interacts with LILRB1
CC       and LILRB2. Interacts with LILRB4. Interacts with FCRL2 and FCRL4.
CC       Interacts with FCRL3 and FCRL6 (tyrosine phosphorylated form).
CC       Interacts with CD84. Interacts with CD300LF. Interacts with CDK2.
CC       Interacts with KIR2DL1; the interaction is enhanced by ARRB2. Interacts
CC       (via SH2 1 domain) with ROS1; the interaction is direct and promotes
CC       ROS1 dephosphorylation. Interacts with EGFR; inhibits EGFR-dependent
CC       activation of MAPK/ERK. Interacts with the tyrosine phosphorylated form
CC       of PDPK1 (By similarity). Interacts with CEACAM1 (via cytoplasmic
CC       domain); this interaction depends on the monomer/dimer equilibrium and
CC       is phosphorylation-dependent (By similarity). Interacts with MPIG6B
CC       (via ITIM motif). Interacts with KLRI1 and KLRI2 (PubMed:18713988).
CC       Interacts with moesin/MSN. Interacts with CLEC12B (via ITIM motif) (By
CC       similarity). Interacts with polymerase II components POLR2C and POLR2J;
CC       these interactions recruit RNA polymerase II to the PCK1 promoter.
CC       Interacts with TNFRSF10A; this interaction enables the inhibition of T-
CC       cell receptor signaling via LCK (By similarity).
CC       {ECO:0000250|UniProtKB:P29350, ECO:0000250|UniProtKB:P29351,
CC       ECO:0000269|PubMed:17068200, ECO:0000269|PubMed:18713988}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17068200}. Nucleus
CC       {ECO:0000269|PubMed:17068200}. Note=In neurons, translocates into the
CC       nucleus after treatment with angiotensin II. Shuttles between the
CC       cytoplasm and nucleus via its association with PDPK (By similarity).
CC       {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: Highly expressed in embryonic cerebral cortex
CC       between day 18 and up to birth. Expression levels decrease after birth
CC       (at protein level). {ECO:0000269|PubMed:17068200}.
CC   -!- DOMAIN: The N-terminal SH2 domain functions as an auto-inhibitory
CC       domain, blocking the catalytic domain in the ligand-free close
CC       conformation. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues. Binding of KITLG/SCF to KIT
CC       increases tyrosine phosphorylation (By similarity). Phosphorylation at
CC       Tyr-566 by LYN enhances phosphatase activity. Phosphorylation at Thr-
CC       396 by TAOK3 leads to polyubiquitination and subsequent proteasomal
CC       degradation (By similarity). {ECO:0000250|UniProtKB:P29350,
CC       ECO:0000250|UniProtKB:P29351}.
CC   -!- PTM: Ubiquitinated after phosphorylation by TAOK3. Ubiquitinated by a
CC       cooperation between ITCH and WWP2 via 'Lys-27'-mediated polyubiquitin
CC       chains resulting in the reduction of its association with LCK.
CC       {ECO:0000250|UniProtKB:P29350}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class 2 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U77038; AAD00262.1; -; mRNA.
DR   RefSeq; NP_446360.1; NM_053908.1.
DR   AlphaFoldDB; P81718; -.
DR   SMR; P81718; -.
DR   BioGRID; 250571; 3.
DR   DIP; DIP-47802N; -.
DR   IntAct; P81718; 5.
DR   STRING; 10116.ENSRNOP00000059867; -.
DR   iPTMnet; P81718; -.
DR   PhosphoSitePlus; P81718; -.
DR   jPOST; P81718; -.
DR   PaxDb; 10116-ENSRNOP00000059867; -.
DR   GeneID; 116689; -.
DR   KEGG; rno:116689; -.
DR   UCSC; RGD:620660; rat.
DR   AGR; RGD:620660; -.
DR   CTD; 5777; -.
DR   RGD; 620660; Ptpn6.
DR   eggNOG; KOG0790; Eukaryota.
DR   InParanoid; P81718; -.
DR   OrthoDB; 2911650at2759; -.
DR   PhylomeDB; P81718; -.
DR   Reactome; R-RNO-114604; GPVI-mediated activation cascade.
DR   Reactome; R-RNO-1433559; Regulation of KIT signaling.
DR   Reactome; R-RNO-201556; Signaling by ALK.
DR   Reactome; R-RNO-210990; PECAM1 interactions.
DR   Reactome; R-RNO-388841; Costimulation by the CD28 family.
DR   Reactome; R-RNO-389948; PD-1 signaling.
DR   Reactome; R-RNO-432142; Platelet sensitization by LDL.
DR   Reactome; R-RNO-512988; Interleukin-3, Interleukin-5 and GM-CSF signaling.
DR   Reactome; R-RNO-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-877300; Interferon gamma signaling.
DR   Reactome; R-RNO-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-RNO-912694; Regulation of IFNA/IFNB signaling.
DR   Reactome; R-RNO-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   PRO; PR:P81718; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0042105; C:alpha-beta T cell receptor complex; ISO:RGD.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0050839; F:cell adhesion molecule binding; ISO:RGD.
DR   GO; GO:0005126; F:cytokine receptor binding; IPI:RGD.
DR   GO; GO:0046703; F:natural killer cell lectin-like receptor binding; IPI:RGD.
DR   GO; GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; IBA:GO_Central.
DR   GO; GO:0140031; F:phosphorylation-dependent protein binding; ISO:RGD.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISO:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; ISO:RGD.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0050853; P:B cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; ISS:UniProtKB.
DR   GO; GO:0036006; P:cellular response to macrophage colony-stimulating factor stimulus; IEP:RGD.
DR   GO; GO:1905867; P:epididymis development; ISO:RGD.
DR   GO; GO:0002244; P:hematopoietic progenitor cell differentiation; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISO:RGD.
DR   GO; GO:0035855; P:megakaryocyte development; ISO:RGD.
DR   GO; GO:0000278; P:mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0002924; P:negative regulation of humoral immune response mediated by circulating immunoglobulin; ISO:RGD.
DR   GO; GO:0106015; P:negative regulation of inflammatory response to wounding; ISO:RGD.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0033007; P:negative regulation of mast cell activation involved in immune response; ISO:RGD.
DR   GO; GO:0050732; P:negative regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; ISO:RGD.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISO:RGD.
DR   GO; GO:0030220; P:platelet formation; ISO:RGD.
DR   GO; GO:0033630; P:positive regulation of cell adhesion mediated by integrin; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0006470; P:protein dephosphorylation; ISS:UniProtKB.
DR   GO; GO:0045577; P:regulation of B cell differentiation; ISO:RGD.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0051279; P:regulation of release of sequestered calcium ion into cytosol; ISO:RGD.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0042098; P:T cell proliferation; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   CDD; cd14606; PTPc-N6; 1.
DR   CDD; cd09931; SH2_C-SH2_SHP_like; 1.
DR   CDD; cd10340; SH2_N-SH2_SHP_like; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   Gene3D; 3.30.505.10; SH2 domain; 2.
DR   InterPro; IPR052123; Non-rcpt_Tyr_Phosphatase.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR036860; SH2_dom_sf.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR012152; Tyr_Pase_non-rcpt_typ-6/11.
DR   PANTHER; PTHR46257; TYROSINE-PROTEIN PHOSPHATASE CORKSCREW; 1.
DR   PANTHER; PTHR46257:SF4; TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 6; 1.
DR   Pfam; PF00017; SH2; 2.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000929; Tyr-Ptase_nr_6; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   PRINTS; PR00401; SH2DOMAIN.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SMART; SM00252; SH2; 2.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   SUPFAM; SSF55550; SH2 domain; 2.
DR   PROSITE; PS50001; SH2; 2.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Hydrolase; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Protein phosphatase; Reference proteome; Repeat; SH2 domain;
KW   Ubl conjugation.
FT   CHAIN           1..613
FT                   /note="Tyrosine-protein phosphatase non-receptor type 6"
FT                   /id="PRO_0000094760"
FT   DOMAIN          6..102
FT                   /note="SH2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191,
FT                   ECO:0000305"
FT   DOMAIN          112..215
FT                   /note="SH2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00191,
FT                   ECO:0000305"
FT   DOMAIN          246..517
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          549..598
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        556..594
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        455
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000255|PROSITE-ProRule:PRU10044"
FT   BINDING         421
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         455..461
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         502
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         59
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P29351"
FT   MOD_RES         66
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29350"
FT   MOD_RES         379
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29351"
FT   MOD_RES         396
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P29350"
FT   MOD_RES         538
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P29351"
FT   MOD_RES         566
FT                   /note="Phosphotyrosine; by LYN"
FT                   /evidence="ECO:0000250|UniProtKB:P29350"
FT   CROSSLNK        310
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P29350"
SQ   SEQUENCE   613 AA;  69578 MW;  29364B22E8F45C87 CRC64;
     MLSRGWFHRD LSGPDAETLL KGRGVPGSFL ARPSRKNQGD FSLSVRVDDQ VTHIRIQNSG
     DFYDLYGGEK FATSTELVEY YTQQQGILQD RDGTIIHLKY PLNCSDPTSE RWYHGHMSGG
     QAESLLQAKG EPWTFLVRES LSQPGDFVLS VLNDQPKAAP GSPLRVTHIK VMCEGGRYTV
     GGSETFDSLT DLVEHFKKTG IEEASGAFVY LRQPYYATRV NAADIENRVL ELNKKQESED
     TAKAGFWEEF ESLQKQEAKN LHQRLEGQRP ENKSKNRYKN ILPFDHSRVI LQGRDSNIPG
     SDYINANYVK NQLLGPDENS KTYIASQGCL DATVNDFWQM AWQENTRVIV MTTREVEKGR
     NKCVPYWPEV GTQRVYGLYS VTNCKEHDTA EYKLRTLQIS PLDNGDLVRE IWHYQYLSWP
     DHGVPSEPGG VLSFLDQINQ RQESLPHAGP IIVHCSAGIG RTGTIIVIDM LMESVSTKGL
     DCDIDIQKTI QMVRAQRSGM VQTEAQYKFI YVAIAQFIET TKKKLEIIQS QRGQESEYGN
     ITYPPALRSA HAKASRTSSK HKEEVYENVH SKNKKEEKVK KQRSADKEKN KGSLKRNISL
     TPCRGLRWAD RDL
//
